Building on years of experience in large pharma and biotechnology companies our bioscience team offers capabilities specialising in bioassay development, pharmacological profiling and compound screening.
Significant experience of different target classes and the use of cutting edge technologies ensure client projects are delivered to time and budget.
Important information: Aurelia Bioscience website pages now redirect to Charnwood Molecular following the company’s acquisition. If you have any questions about our bioscience services or specific content you are looking for please contact email@example.com
Wide range of technologies
Our team has worked in pre-clinical discovery, designing and developing low, medium and high throughput assays in both cellular and non-cellular assay formats.
Therefore, we have experience of a wide range of technologies designed to prosecute these activities in a scalable manner whilst bringing to bear technological developments that have the ability to probe ever further into the molecular interactions from which the drugs of the future may be identified.
Whatever your therapeutic area or target class we are able to apply our expertise to your project.
View out latest video on formation and growth of a spheroid using the IncuCyte SX5.
We work across the drug discovery pipeline, from target identification, validation and hit to lead, through to lead identification and optimisation.
At Charnwood Molecular , we have significant experience of different target classes and use cutting edge technologies to deliver client projects in a timely, efficient and cost-effective manner.
We can offer standalone biology-based project support through to a fully integrated approach to drug discovery and development, incorporating our services in medicinal and process research chemistry.
Our leadership has decades of large pharma experience in drug discovery gained in companies including Hoffmann La Roche, Smith Kline Beecham, GlaxoWellcome, AstraZeneca, ICI and UCB.
Find out more about our scientific team.
Bioscience capabilities and technologies
- High throughput screening
- Cell based screening
- Phenotypic screening
- Cell culture services
- Biochemical screening
- Instrument & reagent validation
- Liquid handling
We believe biophysics-based techniques can play a key role in the success of any drug discovery project.
Biophysical methods are especially valuable when no historic data to suggest the structure of chemical matter is available.
We have brought together a suite of cutting-edge, market-leading biophysical technologies to provide insights into molecular interactions in many different project settings.
Find out more about the following biophysical techniques: